ResearcherNorthwestern UniversityActive in the last 2 years
Frank H. Miller
Matched on ORCID iD 0000-0001-9506-9411; OpenAlex author ID A5082906150, A5091229453. Sources: OpenAlex.
Their work
- Papers
- 13 (first author 1, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 38
2011: 1 paper · 2012: none · 2013: none · 2014: 2 papers · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 3 papers
Papers 13
- Undifferentiated pancreatic cancer with osteoclast-like giant cells: imaging features. Last author DOI 10.1016/j.crad.2026.107372↗
- Prevalence and Clinical Significance of Abnormal Findings on Pre-Diagnostic Imaging in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000002688↗
- Invited Commentary: Early Detection of Pancreatic Cancer: Are We Up for the Challenge? Co-author DOI 10.1148/rg.250222↗
- Cyst-X: AI-Powered Pancreatic Cancer Risk Prediction from Multicenter MRI in Centralized and Federated Learning Co-author DOI 10.21203/rs.3.rs-7236860/v1↗
- Predicting Pancreatic Ductal Adenocarcinoma Occurrence Up to 10 Years in Advance Using Features of the Main Pancreatic Duct in Pre-Diagnostic CT Scans. Co-author DOI 10.3390/cancers17111886↗
- Pancreatic Cancer and Its Mimics. Co-author DOI 10.1148/rg.230054↗
- Differentiation of focal autoimmune pancreatitis from pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s00261-019-02210-0↗
- Inflammatory mimickers of pancreatic adenocarcinoma. Last author DOI 10.1007/s00261-019-02233-7↗
- Pancreatic cancer screening. First author DOI 10.1007/s00261-017-1308-z↗
- Loss of intratumoral macroscopic fat in renal angiomyolipoma following chemoradiation therapy for pancreatic cancer. Co-author DOI 10.1259/bjrcr.20150439↗
- Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic associatio… Co-author DOI 10.1053/j.gastro.2013.11.004↗
- Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Associatio… Co-author DOI 10.1148/radiol.13131184↗
- Change in the growth rate of localized pancreatic adenocarcinoma in response to gemcitabine, bevacizumab, and radiation therapy on MDCT. Co-author DOI 10.1016/j.ijrobp.2010.05.060↗
Closest collaborators
The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Camila Lopes Vendrami · 4 shared papers, 2020–2025 · strength 0.67
- Paper Pancreatic Cancer and Its Mimics. DOI 10.1148/rg.230054↗
- Paper Predicting Pancreatic Ductal Adenocarcinoma Occurrence Up to 10 Years in Advance Using Features of the Main Pancreatic … DOI 10.3390/cancers17111886↗
- Paper Differentiation of focal autoimmune pancreatitis from pancreatic ductal adenocarcinoma. DOI 10.1007/s00261-019-02210-0↗
- Rajesh N. Keswani · 2 shared papers, 2025–2026 · strength 0.56
- Paper Prevalence and Clinical Significance of Abnormal Findings on Pre-Diagnostic Imaging in Pancreatic Ductal Adenocarcinoma. DOI 10.1097/mpa.0000000000002688↗
- Paper Cyst-X: AI-Powered Pancreatic Cancer Risk Prediction from Multicenter MRI in Centralized and Federated Learning DOI 10.21203/rs.3.rs-7236860/v1↗
- Benjamin M. Moy · 1 shared paper, 2026 · strength 0.39
- Kumaresan Sandrasegaran · 1 shared paper, 2026 · strength 0.36
- Paul Nikolaidis · 2 shared papers, 2018–2023 · strength 0.34
- Vahid Yaghmai · 3 shared papers, 2011–2025 · strength 0.29
- Paper Predicting Pancreatic Ductal Adenocarcinoma Occurrence Up to 10 Years in Advance Using Features of the Main Pancreatic … DOI 10.3390/cancers17111886↗
- Paper Loss of intratumoral macroscopic fat in renal angiomyolipoma following chemoradiation therapy for pancreatic cancer. DOI 10.1259/bjrcr.20150439↗
- Paper Change in the growth rate of localized pancreatic adenocarcinoma in response to gemcitabine, bevacizumab, and radiation… DOI 10.1016/j.ijrobp.2010.05.060↗
- Kunal Kothari · 2 shared papers, 2020 · strength 0.27
- A. Jawahar · 1 shared paper, 2023 · strength 0.22
- Temel Tirkes · 1 shared paper, 2025 · strength 0.18
- Lixia Wang · 1 shared paper, 2025 · strength 0.18
- James Leonard Buxbaum · 1 shared paper, 2025 · strength 0.18
- Sehrish Javed · 1 shared paper, 2025 · strength 0.18
- Christie Y. Jeon · 1 shared paper, 2025 · strength 0.18
- Stephen Jacob Pandol · 1 shared paper, 2025 · strength 0.18
- Srinivas Gaddam · 1 shared paper, 2025 · strength 0.18
- Debiao Li · 1 shared paper, 2025 · strength 0.18
- Touseef Ahmad Qureshi · 1 shared paper, 2025 · strength 0.18
- Wolfram Goessling · 1 shared paper, 2025 · strength 0.18
- Yasmin Genevieve Hernandez-Barco · 1 shared paper, 2025 · strength 0.18
- Ulaş Bağcı · 1 shared paper, 2025 · strength 0.17
- Candice W. Bolan · 1 shared paper, 2025 · strength 0.17
- Marco J. Bruno · 1 shared paper, 2025 · strength 0.17
- Tamas A. Gonda · 1 shared paper, 2025 · strength 0.17
- Michael B. Wallace · 1 shared paper, 2025 · strength 0.17
- Chris M. Lindquist · 1 shared paper, 2018 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.